When was Biorez founded?

Biorez was founded in 2008 and raised its 1st funding round within a year of its incorporation.

Where is Biorez located?

Biorez is headquartered in New Haven, United States.

How many employees does Biorez have?

As of Mar 31, 2026, the latest employee count at Biorez is 7.

Is Biorez a funded company?

Biorez is a funded company, having raised a total of $37.3M across 13 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on May 02, 2008.

When was the latest funding round of Biorez?

Biorez's latest funding was a $***** Series C round on Jun 24, 2021, with participation from 0 investor.

Where does Biorez rank among its competitors?

Biorez ranks 10th amongst 70 active competitors, of which 20 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Nanochon, which secured $4.1M in Dec, 2025.

Who are the top competitors of Biorez?

Biorez's top competitors include Miach Orthopaedics, Nanochon and Tenex Health. Among them, Nanochon secured the most recent funding round in December, 2025.

Biorez - 2026 Company Profile, Team, Funding & Competitors

Biorez is a series C company based in New Haven (United States), founded in 2008 by Kevin Rocco, Cato Laurencin and Joseph Reilly. It operates as a Synthetic products for soft tissue regeneration of anterior cruciate ligament injuries. Biorez has raised $37.3M in funding from investors like Connecticut Innovations, MentorTech Ventures and New York Angels. The company has 70 active competitors, including 20 funded and 14 that have exited. Its top competitors include companies like Miach Orthopaedics, Nanochon and Tenex Health.

Company Details

Biorez is a clinical-stage regenerative medicine company engaged in the development of tissue-engineered scaffold implants that are fully bioresorbable and can remodel into functional tissue. Their products cater mainly to the soft tissue regeneration segment in the sports medicine market. Its product L-C Ligament is a bioresorbable scaffold, that uses three-dimensional woven polymeric fibers for soft tissue regeneration of the anterior cruciate ligament (ACL) of the knee, as well as for treatment of ACL tears. The company is also developing a 3-dimensional braided surgical mesh for breast reconstruction and hernia repair.

Website: biorez.com
Email ID: *****@biorez.com
Part Of

Key Metrics

Founded Year

2008

Location

New Haven, United States

Stage

Series C

Total Funding

$37.3M in 13 rounds

Latest Funding Round

Series C, Jun 24, 2021, $*****

Investors

Connecticut Innovations & 9 more

Ranked

10^th among 70 active competitors

Employee Count

7 as on Mar 31, 2026

Similar Companies

Miach Orthopaedics & 98 more

View Biorez's full profile

Biorez has raised a total funding of $37.3M over 13 rounds. Its first funding round was on May 02, 2008. Biorez has 10 institutional investors.

Here is the list of recent funding rounds of Biorez:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 24, 2021	3210702	Series C	6259597	6455959	5812157	2776951
Sep 09, 2020	1655890	Series C	3822325	8466267	7203658	Connecticut Innovations & 3 more
Jul 11, 2019	8705536	Series C	4934066	5210411	3907566	7658319

Access funding benchmarks and valuations. Sign up today!

View details of Biorez's funding rounds and investors

The founders of Biorez are Kevin Rocco, Cato Laurencin and Joseph Reilly.

Here are the details of Biorez's key team members:

Kevin Rocco: Founder & CEO of Biorez.
Cato Laurencin: Former Co-Founder of Biorez.
Joseph Reilly: Co-Founder of Biorez.

View details of Biorez's Founder profiles and Board Members

Biorez's employee count trend

Biorez has 7 employees as of Mar 26. Here is Biorez's employee count trend over the years:

Uncover Biorez's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Biorez include Miach Orthopaedics, Nanochon and Tenex Health. Here is the list of Top 10 competitors of Biorez, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Miach Orthopaedics 2016, Boston (United States), Series B	Developer of surgical implants for connective tissue repair	$72.5M	Sectoral, Endeavour Vision & 10 others	61/100
2nd	Nanochon 2016, Burke (United States), Seed	Developer of 3D-printed implants for treating joint injuries	$11.3M	cultivate(MD), University of Virginia & 11 others	55/100
3rd	Tenex Health 2009, Lake (United States), Acquired	Minimally invasive ultrasonic medical devices for chronic tendon pain treatment	$18.5M	VCI Partners, SWK Holdings & 2 others	54/100
4th	Abanza Tecnomed 2014, Pamplona (Spain), Seed	Developer of surgical instruments for sports medicine	$5.19M	Clave, Orza & 3 others	51/100
5th	Aroa Biosurgery 2008, Mangere (New Zealand), Public	Developer of medical and surgical products for soft tissue reconstruction	-	Alium Capital, Cure Kids Ventures & 2 others	47/100
6th	Rotation Medical 2009, Minneapolis (United States), Acquired	Device for rotator cuff disease	$54.6M	Life Sciences Partners, New Enterprise Associates ... & 2 others	46/100
7th	Nurami Medical 2014, Nazareth (Israel), Series C	Developer of nanofiber and sealant technology for the soft tissue repair	$42.4M	Almeda Ventures, Israel Innovation Authority ... & 5 others	46/100
8th	OrthoSpace 2009, Caesarea (Israel), Acquired	Biodegradable balloon system for rotator cuff tear	$23.6M	Kreos Capital, Triventures & 6 others	46/100
9th	Cayenne Medical 2005, Phoenix (United States), Acquired	Pioneering sports medicine solutions, optimizing patient care through innovation and integration	$46.3M	Fletcher Spaght, Split Rock Partners & 7 others	45/100
10th	Biorez 2008, New Haven (United States), Series C	Synthetic products for soft tissue regeneration of anterior cruciate ligament injuries	$37.3M	The Vertical Group, Center for Innovative Technology ... & 8 others	43/100